Compassionate Advocate in Cancer Care

September 7th 2024, 2:00pm

By Tina M. Mason, PhD, APRN, AOCN, AOCNS, FCNS

An extraordinary oncology nurse guided cancer care for a man who was legally blind.

My Worries About Being Old as an MDS Survivor

September 6th 2024, 5:00pm

By Jane Biehl Ph.D.

Having myelodysplastic syndromes has taught me to cherish every day and to pursue the things that matter to me, like publishing a book I’ve been writing.

Roger O’Donnell Has Lymphoma, ‘Love Is Blind’ Star Reveals Cancer During Pregnancy and More

September 6th 2024, 3:00pm

By Ashley Chan

From Roger O’Donnell announcing his aggressive lymphoma diagnosis to “Love Is Blind’s” Shaina Hurley opening up about her cervical cancer while three months pregnant, here’s what’s happening in the oncology space this week.

LL Treatment Roadmap: Navigating First-Line Options With Your Doctor

September 6th 2024, 2:50pm

The discussion will cover the current CLL treatment landscape, including first-line and later-line options; the medical experts will review first-line treatments, approach to treatment selection, factors influencing recommendations, and strategies for shared decision-making with patients.

Watchful Waiting in CLL: When Waiting Is Treating

September 6th 2024, 2:13pm

Medical experts explain CLL’s slow progression and its impact on treatment timing, and they also discuss the watch-and-wait approach, patient concerns, and how to address anxiety about delaying treatment.

Boruzu Approved by FDA For Multiple Myeloma, Mantle Cell Lymphoma

September 6th 2024, 1:48pm

By Alex Biese

Boruzu, an injectable presentation of Velcade, has been approved by the FDA for patients who either have multiple myeloma or mantle cell lymphoma.

What to Expect With a Stem Cell Transplant for Leukemia

September 6th 2024, 1:00pm

By Brielle Benyon

Dr. Partow Kebriaei explains what patients can expect before, during and after an allogeneic stem cell transplant to treat acute lymphoblastic leukemia.

Cancer Vaccine UV1 Shows No Survival Benefit in Head and Neck Cancer

September 5th 2024, 9:00pm

By Alex Biese

A trial showed no overall survival or progression-free survival benefit from the addition of UV1 to Keytruda in patients with HNSCC.

‘Tempo’ of MDS Helps With Timing for Stem Cell Transplants

September 5th 2024, 7:00pm

By Ashley Chan

For patients with MDS, close monitoring by doctors may help determine the appropriate timing to undergo stem cell transplants before the disease worsens.

After Breast Cancer, I Appreciate My Husband More Than Ever

September 5th 2024, 5:00pm

By Laura Yeager

Having breast cancer has allowed me to truly appreciate and love my husband even more these days.

FDA to Speed Up Review of IBI363 for Advanced Melanoma

September 5th 2024, 3:00pm

By Brielle Benyon

The Food and Drug Administration granted a fast track designation to IBI363 for patients with unresectable advanced or metastatic melanoma.

Invasive Ductal Carcinoma: Two Poems on My Experience

September 5th 2024, 1:00pm

By Danyelle L. Walker

I wrote these poems as a testament to strength, courage and resilience for all patients affected by cancer.

Immunotherapy Combination Elicit Waves of Response in Advanced Melanoma

September 4th 2024, 9:00pm

By Alex Biese

A new algorithm has found that combining immune checkpoint inhibitors bolsters immune response among some patients with advanced melanoma.

Metastasis-Directed Therapy Shows Benefits in Some Pancreatic Cancer

September 4th 2024, 7:00pm

By Ashley Chan

Patients with oligometastatic pancreatic cancer showed better progression-free survival after receiving metastasis-directed therapy with chemotherapy.

Rest is Vital After a Cancer Diagnosis

September 4th 2024, 5:00pm

By Bonnie Annis

A disease, such as cancer, that affects a person’s physical limitations can catalyze learning to rest, which is something I recently realized.